News | February 08, 2022
AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
Takes charge to lead business innovation, strategy, alliance & partnerships
This is the ninth Covid-19 vaccine approved in India
Key takeaways of recent quarter & conference call highlights
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Subscribe To Our Newsletter & Stay Updated
